Page last updated: 2024-12-07

23-seleno-25-homotaurocholic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123829
CHEMBL ID3707262
CHEBI ID135844
MeSH IDM0104290

Synonyms (19)

Synonym
CHEBI:135844
75018-70-1
ethanesulfonic acid, 2-(((((3alpha,5beta,7alpha,12alpha,20s)-3,7,12-trihydroxy-20-methylpregnan-21-yl)seleno-75se)acetyl)amino)-
xk88n6zjhp ,
se(75)hcat
(75)seleno-homocholic acid-taurine
tauro-23-selena-25-homotaurocholic acid
se-hcat
unii-xk88n6zjhp
23-seleno-25-homotaurocholic acid
CHEMBL3707262
tauroselcholic acid se-75
ethanesulfonic acid, 2-(((((3.alpha.,5.beta.,7.alpha.,12.alpha.,20s)-3,7,12-trihydroxy-20-methylpregnan-21-yl)seleno-75se)acetyl)amino)-
selenium (75se) tauroselcholic acid [who-dd]
selenium (75se) tauroselcholic acid
Q7439754
2-[[2-[(2s)-2-[(3r,5s,7r,8r,9s,10s,12s,13s,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]propyl](75se)selanylacetyl]amino]ethanesulfonic acid
2-[[[[(3alpha,5beta,7alpha,12alpha,20s)-3,7,12-trihydroxy-20-methylpregnan-21-yl]seleno-75se]acetyl]amino]ethanesulfonic acid
DTXSID601108465

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" There were no serious adverse events."( Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
Borup Andersen, T; Borup, C; Graff, J; Gregersen, T; Hansen, SH; Jørgensen, SPG; Munck, LK; Nøjgaard, C; Rainteau, D; Rumessen, JJ; Timm, HB; Vinter-Jensen, L; Wildt, S; Zaremba, A, 2023
)
0.91
" Colesevelam was safe during the treatment."( Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
Borup Andersen, T; Borup, C; Graff, J; Gregersen, T; Hansen, SH; Jørgensen, SPG; Munck, LK; Nøjgaard, C; Rainteau, D; Rumessen, JJ; Timm, HB; Vinter-Jensen, L; Wildt, S; Zaremba, A, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
"Colestyramine and colestipol are generally effective treatments of gastrointestinal symptoms from BAM, but may be poorly tolerated and reduce the bioavailability of co-administered agents."( Systematic review: the management of chronic diarrhoea due to bile acid malabsorption.
Green, J; Turner, J; Wilcox, C, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
corticosteroid hormoneAny of a class of steroid hormones that are produced in the adrenal cortex.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (135)

TimeframeStudies, This Drug (%)All Drugs %
pre-199040 (29.63)18.7374
1990's46 (34.07)18.2507
2000's6 (4.44)29.6817
2010's34 (25.19)24.3611
2020's9 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.15 (24.57)
Research Supply Index5.05 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (5.44%)5.53%
Reviews18 (12.24%)6.00%
Case Studies3 (2.04%)4.05%
Observational3 (2.04%)0.25%
Other115 (78.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]